ENDOLOGIX INC /DE/

Delisted

CIK 1013606fmd_08RXQZENPVHK93JBFW0A97XH4PManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2020, 42 periods

Income Statement · Annual · Millions · USD
Line item	FY2010	FY2011	FY2012	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019
Total revenues	–	–	–	–	–	–	193	181	156	143
Cost of revenue	15	19	25	33	42	52	69	60	65	52
Gross profit	52	65	81	100	106	102	124	121	92	91
Research and development	9	17	17	16	22	26	32	21	21	18
Selling, general and administrative	45	60	74	85	100	108	149	128	120	101
Total operating expenses	56	83	103	110	135	155	219	163	160	134
Operating income	(4)	(18)	(22)	(10)	(29)	(53)	(95)	(42)	(68)	(43)
Interest expense	0	0	0	0	6	7	16	22	28	35
Interest and investment income	0	0	0	0	0	0	0	0	0	0
Other non-operating income (expense)	(0)	(0)	0	3	(6)	1	(59)	(25)	(11)	(27)
Income before taxes	(4)	(29)	(35)	(16)	(32)	(60)	(154)	(67)	(79)	(69)
Income tax expense	(15)	(0)	1	(0)	(0)	(9)	0	(0)	0	(5)
Net income from continuing operations	11	(29)	(36)	(16)	(32)	(50)	(155)	(66)	(80)	(65)
Net income	11	(29)	(36)	(16)	(32)	(50)	(155)	(66)	(80)	(65)